Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma

Acta Pharmaceutica

Volumn 62, Issue 1, 2012, Pages 45-58

  Sharma, Ritesh N ^a   Pancholi, Shyam Sunder ^b  

^a GANPAT UNIVERSITY   (India)

^b Gujarat Technological University   (India)

Author keywords

amlodipine; hydrochlorothiazide; plasma; preliminary pharmacokinetic; RP HPLC; triple drug combination; valsartan

Indexed keywords

AMLODIPINE; HYDROCHLOROTHIAZIDE; TELMISARTAN; VALSARTAN;

ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN TISSUE; PLASMA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STANDARD; VALIDATION STUDY;

EID: 84859457632     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0004-3     Document Type: Article

References (17)

1. N. Koseki, H. Kawashita, H. Hara, M. Niina, M. Tanaka, R. Kawai, Y. Nagae and N. Masuda, Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry, J. Pharm. Biomed. Anal. 43 (2007) 1769-1774; DOI: 10.1016/j.jpba.2006.12.030. (Pubitemid 46453072)
2. M. Doménech and A. Coca, Role of triple fixed combination valsartan, amlodipine and hydro-chlorothiazide in controlling blood pressure, Patient Pref. Adh. 4 (2010) 105-113.
3. The Merck Index (Ed. S. Budavari), 13th ed. Merck & Co. Inc., Whitehouse Station (NJ), 2001.
4. N. Daneshtalab, R. Z. Lewanczuk and F. Jamali, High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method, J. Chro-matogr. B. 766 (2002) 345-349; DOI: 10.1016/S0378-4347(01)00507-2. (Pubitemid 34142367)
5. E. K. Schmidt, K. H. Antonin, G. Flesch and A. Racine-Poon, An interaction study with cime-tidine and the new angiotensin II antagonist valsartan, Eur. J. Clin. Pharmacol. 53 (1998) 451-458; DOI: 10.1007/ s002280050406. (Pubitemid 28154746)
6. F. Waldmeier, G. Flesch, P. Muller, T. Winkler, H. P. Kriemler, P. Buhlmayer and M. De Gasparo, Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose, Xenobiotica 27 (1997) 59-71; DOI: 10.1080/004982597240767 (Pubitemid 27068372)
7. P. Pickkers, A. D. Hughes, F. G. M. Russel, T. Thien and P. Smits, Thiazide-induced vasodilation in humans is mediated by potassium channel activation, Hypertension 32 (1998) 1071-1076. (Pubitemid 29001439)
8. S. G. Chrysant, Fixed low-dose drug combination for the treatment of hypertension, Arch. Fam. Med. 7 (1998) 370-376; DOI: 10.1001/archfami.7.4.370. (Pubitemid 128433260)
9. J. Macek, J. Kĺima and P. Ptácek, Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography, J. Chromatogr. B 832 (2006) 169-172; DOI: 10.1016/j.jchromb. 2005.12.035. (Pubitemid 43213025)
10. B. Kofyigit-Kaymakfoglu, S. Unsalan and S. Rollas, Determination and validation of ketopro-fen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography, Pharmazie 61 (2006) 586-589. (Pubitemid 44098024)
11. Zarghi, S. M. Foroutan, A. Shafaati and A. Khoddam, Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies, Farmaco 60 (2005) 789-792; DOI: 10.1016/j.farmac.2005. 06.012. (Pubitemid 41317706)
12. R. V. S. Nirogi, V. N. Kandikere, K. Mudigonda, M. Shukla and S. Maurya, Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma, Biomed. Chromatogr. 20 (2006) 833-842; DOI: 10.1002/bmc.600. (Pubitemid 44430541)
13. L. Li, J. Sun, P. Yang and Z. He, Liquid chromatography-electrospray ionization mass spectro-metric method for the determination of hydrochlorothiazide in human plasma: application to a pharmacokinetic study, Anal. Lett. 39 (2006) 2797-2807; DOI: 10.1080/00032710600867465. (Pubitemid 44851132)
14. H. Li, Y. Wang, Y Jiang, Y Tang, J. Wang, L. Zhao and J. Gu, A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma, J. Chromatog. B 852 (2007) 436-442; DOI: 10.1016/j.jchromb.2007.02. 014. (Pubitemid 46830149)
15. M. Gelebier, M. S. Kaynak, S. Altnöz and S. Ahin, Validated HPLC method development: the simultaneous analysis of amlodipine and valsartan in samples for liver perfusion studies, Ha-cettepe Univ. J. Fac. Phar. 28 (2008) 15-30
16. FDA, Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, FDA, CDER and CVM, Rockville 2001
17. EMEA, Draft Guidelines on Validation of Bioanalytical Methods, Committee for Medicinal Products for Human Use, EMEA, London 2009.